Surgical Robot Maker Cornerstone Robotics Raises ~$200M in Oversubscribed Round to Accelerate Global Expansion

On November 10, Cornerstone Robotics, a leading Chinese innovative surgical robotics company, announced the completion of a new funding round of approximately $200 million, which was oversubscribed. The round attracted investments from Hong Kong Investment Corporation, a global strategic investor, and a top-tier global sovereign wealth fund, alongside continued support from existing investors including Qiming Venture Partners, Daohe Investment, Gaorong Ventures, and K2VC. Gaorong Ventures co-led Cornerstone Robotics' angel round in 2019 and participated in multiple subsequent rounds, and continued to increase its stake in this round.

The proceeds will be primarily used to accelerate commercialization in China and overseas markets, as well as to drive the development and clinical registration of next-generation products.

Backed by HKIC and Top-Tier Capital

Accelerating Global Expansion Together

Hong Kong Investment Corporation (HKIC) is a patient capital investment institution wholly owned by the Hong Kong SAR Government and investing on its behalf. As a technology innovation company that grew out of the Guangdong-Hong Kong-Macao Greater Bay Area, Cornerstone Robotics' continued and strong support from HKIC — including its lead investment in this round — represents not only an authoritative endorsement of the company's product innovation and global commercialization capabilities, but also a vivid demonstration of Hong Kong's local capital and government commitment to nurturing tech unicorns with confidence and long-term dedication.

With its leading technology and broad prospects in the surgical robotics field, Cornerstone Robotics successfully attracted a major investment from a global strategic investor, injecting synergistic growth momentum into the company's critical operations and global footprint. This round also brought in a top-tier global sovereign wealth fund, whose participation will help Cornerstone Robotics expand into overseas markets and advance product market access and regional partnerships. The continued commitment from multiple existing shareholders fully reflects the capital market's strong recognition of and confidence in Cornerstone Robotics' technical approach, commercial progress, and long-term potential.

Core Product Enters Clinical Use

Demonstrating Hardcore Technical Strength

Since its founding in 2019, Cornerstone Robotics has adhered to its vision of "leading medical innovation, caring for global health." Through full-stack self-developed technology and deep integration, it has grown into a unicorn among Chinese innovative surgical robotics companies. The company's core product, the Sentire® laparoscopic surgical robot, has not only received approval from China's National Medical Products Administration (NMPA) but has also been deployed for clinical use at leading hospitals in mainland China, Hong Kong, and Europe.

To date, Cornerstone Robotics has achieved full-chain development covering surgical robot systems, imaging systems, energy platforms, insufflation platforms, and surgical instruments. It has also built multi-category performance testing laboratories and an intelligent mass-production facility exceeding 10,000 square meters, achieving 100% self-production of core components and solving supply chain "chokepoint" and "black box component" challenges.

In August 2025, in close collaboration with a research team from The Chinese University of Hong Kong, Cornerstone Robotics developed the world's first multi-functional automated embodied intelligence platform for surgical robots and successfully completed the world's first autonomous surgery verification in clinical scenarios using the Sentire® laparoscopic surgical robot. This marked the first time a Chinese laparoscopic surgical robot completed a live animal experiment in the embodied intelligence field, validating multi-task autonomous operation and human-robot collaboration capabilities — a critical step forward in verifying the generality and practicality of autonomous surgical robot technology in China.

Making High-Quality, Affordable

Surgical Robotics Accessible Worldwide

Looking ahead, Cornerstone Robotics will continue translating its independent innovation achievements into a driving force for the development of the global smart healthcare ecosystem. Through partnerships with world-class medical and educational institutions, it is deepening its presence in clinical training, technology demonstration, and academic exchange, empowering global healthcare accessibility to reach new heights.

Professor Darwin Ou, Founder and CEO of Cornerstone Robotics, stated: "2025 is a major milestone in Cornerstone Robotics' development journey. We are grateful for the trust and support from our new and existing shareholders — this represents not only recognition of our innovative achievements in practical application, but also strong confidence in Cornerstone Robotics' long-term, high-quality development. Particularly important is the support from HKIC, which demonstrates the government's full commitment and forward-looking approach to investing in technology innovation enterprises, and lays a solid foundation for our upcoming commercialization and global expansion. Going forward, we will continue to be driven by innovation, deepen our global footprint, and make high-quality, affordable surgical robotics accessible to people in need around the world."